Inventor · disambiguated record
Kelly Ibsen
Also filed as: IBSEN KELLY
6 granted patents·6 pending applications·13 citations·filing 2018–2024
79Inventor score
Technology areasA61K
Top patents by PatentIndex Score
12 records- 0193US12233112B2Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereofI2O THERAPEUTICS INC·Filed 2024·Granted Feb 25, 2025·2 cites·14 claims
- 0293US12233111B2Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereofI2O THERAPEUTICS INC·Filed 2024·Granted Feb 25, 2025·2 cites·28 claims
- 0390US11446253B2Ionic liquids for internal deliveryHARVARD COLLEGE·Filed 2018·Granted Sep 20, 2022·8 cites·11 claims
- 0487US12233110B2Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and uses thereofI20 THERAPEUTICS INC·Filed 2024·Granted Feb 25, 2025·1 cites·20 claims
- 0587US2025144180A1Compositions comprising therapeutic proteins or peptides, and uses thereofI2O THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0687US2025161415A1Method of treating disease or disorder using compositions comprising pharmaceutically acceptable salts of amylin analogsI2O THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0786US12350320B2Compositions comprising pharmaceutically acceptable salts of glucagon-like peptide-1 analogs and pharmaceutically acceptable salts of amylin analogs, and uses thereofI2O THERAPEUTICS INC·Filed 2024·Granted Jul 8, 2025·0 cites·30 claims
- 0886US12337029B2Compositions comprising pharmaceutically acceptable salts of amylin analogs and uses thereofI2O THERAPEUTICS INC·Filed 2024·Granted Jun 24, 2025·0 cites·27 claims
- 0969US2023040805A1Ionic liquids for internal deliveryHARVARD COLLEGE·Filed 2022·Application pending·0 cites
- 1069US2023093875A1Ionic liquids for internal deliveryHARVARD COLLEGE·Filed 2022·Application pending·0 cites
- 1163US2024067716A1Ionic liquid formulations for treating inflammatory and autoimmune diseasesI2O THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1261US2024130994A1Ionic liquid formulations for treating diabetesI2O THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kelly Ibsen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →